{"id": "1338457834762227715", "creation": 1607948189.0, "user_id": "44230646", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2 \u2013 https://t.co/sN9FYWM7Di https://t.co/gK2w33VE7z photo BioNTech #covid19, #germany #vaccine #Immunology https://t.co/rDL88OjRml", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#GERMANY", "#VACCINE", "#IMMUNOLOGY"]}